Aptose Biosciences, Oregon Health & Science University, LLS cancer news

Aptose (formerly Lorus Therapeutics Inc.) joined the Beat AML cancer research initiative to create a profile

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE